Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
ASC ICD Reg
1 other identifier
observational
500
1 country
1
Brief Summary
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2017
CompletedFirst Submitted
Initial submission to the registry
July 18, 2018
CompletedFirst Posted
Study publicly available on registry
July 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2028
ExpectedJanuary 22, 2021
January 1, 2021
6 years
July 18, 2018
January 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Successful Implantation
Patient undergoes surgery for ICD device implantation
Two-week follow-up assessment
Study Arms (1)
Patients receiving ICD devices
Eligibility Criteria
Individuals who require ICD to maintain optimal health.
You may qualify if:
- Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- QuesGen Systems Inclead
- Cardio Surgical Partnerscollaborator
Study Sites (1)
Cardio Surgical Partners, LLC
Lehi, Utah, 84043, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2018
First Posted
July 27, 2018
Study Start
August 24, 2017
Primary Completion
August 24, 2023
Study Completion (Estimated)
August 24, 2028
Last Updated
January 22, 2021
Record last verified: 2021-01